The Scientist

» drug development and culture

Most Recent

image: Q&A: From FDA to Industry

Q&A: From FDA to Industry

By | September 27, 2016

Among a subset of US Food and Drug Administration regulators who leave the agency, more than half go to work for pharmaceutical companies, researchers report.

1 Comment

image: Allergan’s Buying Spree Rolls On

Allergan’s Buying Spree Rolls On

By | September 21, 2016

The Ireland-based pharma company makes a $1.7 billion offer to acquire Tobira Therapeutics, a US firm developing liver disease drugs.

0 Comments

image: Feds Demand More Clinical Trial Reporting

Feds Demand More Clinical Trial Reporting

By | September 19, 2016

Expanded US Health and Human Services rules will require the results of more human studies to be made public.

1 Comment

image: Allergan Set to Buy Vitae

Allergan Set to Buy Vitae

By | September 16, 2016

The Irish drugmaker has made a $639 million dollar offer to buy the US-based biopharma.

0 Comments

image: This is Your Brain on Art

This is Your Brain on Art

By | September 1, 2016

Nobel Laureate Eric Kandel talks about how our brains perceive and understand works of art.

1 Comment

In Chapter 13, “Why Is Reductionism Successful in Art?” author Eric Kandel explores what about abstract art challenges the human brain.

1 Comment

image: How Art Can Inform Brain Science, and Vice Versa

How Art Can Inform Brain Science, and Vice Versa

By | September 1, 2016

Reductionism may be the key to bridging the gap between the humanities and the sciences.

0 Comments

image: Notable Science Quotes

Notable Science Quotes

By | September 1, 2016

Sensory discoveries, open-access publishing, and candidates on climate changes

1 Comment

image: The Challenges of Rare-Disease Research

The Challenges of Rare-Disease Research

By | September 1, 2016

With few resources and hesitant investors, basic scientists must rely on clinicians, patient advocates, and their own keen eye for biological connections.

0 Comments

image: Popular Tumor Cell Line Contaminated

Popular Tumor Cell Line Contaminated

By | August 31, 2016

A commercially available glioblastoma cell line appears to be from a different source than its stated origins.

0 Comments

Popular Now

  1. Publishers’ Legal Action Advances Against Sci-Hub
  2. Decoding the Tripping Brain
  3. Metabolomics Data Under Scrutiny
    Daily News Metabolomics Data Under Scrutiny

    Out of 25,000 features originally detected by metabolic profiling of E. coli, fewer than 1,000 represent unique metabolites, a study finds.

  4. Do Microbes Trigger Alzheimer’s Disease?
AAAS